Plus TherapeuticsCNSY
13F holders, Q1 2026 (March 31)24holders −3
4new positions
9sold out
1famous investor
$0.16avg. 13F price*
At the end of Q1 2026, 24 institutions reported holding Plus Therapeutics Inc. (CNSY) in their 13F filings, down 3 from Q4 2025. 4 opened new positions and 9 sold out. The largest holders were Vanguard Capital Management LLC ($396K), Geode Capital Management, LLC ($328K) and BlackRock, Inc. ($289K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Plus Therapeutics Inc.
- CUSIP
- 72941H509
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $64K |
| Exits | 9 | $2.1M |
All 13F filers, Q4 2025 → Q1 2026: 1,148,706 shares bought and 4,934,467 shares sold, net −3,785,761 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Vanguard Capital Management LLC | 0.00% | — | 2,427,098 | $396K |
| Geode Capital Management, LLC | 0.00% | Add +43.7% | 2,016,314 | $328K |
| BlackRock, Inc. | 0.00% | No change | 1,776,372 | $289K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 1,163,776 | $190K |
| State Street Corp. | 0.00% | No change | 468,893 | $76K |
| Northern Trust Corp. | 0.00% | No change | 293,300 | $48K |
| Millennium Management | 0.00% | New | 271,599 | $44K |
| Two Sigma Securities, LLC | 0.00% | Add +155.6% | 142,812 | $23K |
| XTX Topco Ltd | 0.00% | Reduce -53.3% | 116,023 | $19K |
| Citigroup Inc. | 0.00% | Add +91.9% | 93,002 | $15K |
| UBS Group AG | 0.00% | Reduce -90.0% | 87,850 | $14K |
| Mercer Global Advisors Inc. | 0.00% | New | 64,112 | $10K |
| Vanguard Global Advisers, LLC | 0.00% | — | 57,068 | $9K |
| Miller Financial Services LLC | 0.01% | New | 50,000 | $8K |
| Ashton Thomas Private Wealth, LLC | 0.00% | Add +32.1% | 32,913 | $5K |
| Dagco, Inc. | 0.00% | No change | 25,882 | $4K |
| Kestra Advisory Services, LLC | 0.00% | No change | 25,800 | $4K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 13,450 | $2K |
| Forum Financial Management, LP | 0.00% | New | 10,000 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 133 | $21 |
| Wells Fargo & Company | 0.00% | No change | 53 | $9 |
| Sound Income Strategies, LLC | 0.00% | No change | 28 | $4 |
| Barclays PLC | 0.00% | No change | 2 | $0 |
| Danske Bank A/S | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is CNSY's weight in each manager's 13F, not the share of Plus Therapeutics Inc. the manager owns.